HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Senate Health Committee Eyes October Hearing For McClellan

This article was originally published in The Tan Sheet

Executive Summary

The Senate Health Committee appears to be fast-tracking the confirmation process for FDA commissioner nominee Mark McClellan, MD/PhD

You may also be interested in...

FDA Nominee McClellan Would Cement Agency’s Ties To Bush White House

The nomination of White House advisor Mark McClellan, MD/PhD, as FDA commissioner ensures the agency will continue its close alignment with Bush Administration priorities

FDA Commissioner McClellan? HHS’ Thompson Says Nomination Is Imminent

The Bush Administration appears ready to move forward with the nomination of health advisor Mark McClellan, MD/PhD, as FDA commissioner

Internist McClellan Placates Kennedy Industry Concerns; Is That Enough?

White House economic advisor Mark McClellan's viability as the next FDA commissioner may hinge on Senate HELP Committee Chairman Edward Kennedy's (D-Mass.) willingness to look beyond the internist's strong ties to the Bush Administration

Related Content


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts